Release Date: 21/10/14 10:21 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 144.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%